Rolapitant Hydrochloride Hydrate is a neurokinin-1 (NK1) receptor antagonist primarily indicated for the prevention of delayed chemotherapy-induced nausea and vomiting. By selectively blocking the binding… Read more
Rolapitant Hydrochloride Hydrate is a neurokinin-1 (NK1) receptor antagonist primarily indicated for the prevention of delayed chemotherapy-induced nausea and vomiting. By selectively blocking the binding of substance P at NK1 receptors within the central nervous system and gastrointestinal tract, this medication plays a critical role in supportive cancer care. Laboratories utilize this category of reference standards to support rigorous pharmaceutical analysis, including impurity profiling and the validation of analytical methods. This collection provides essential tools for quality control, featuring high-quality standards of the active pharmaceutical ingredient alongside its related impurities, potential degradation products, and metabolites. Furthermore, the inclusion of stable isotope labelled compounds facilitates accurate quantification and structural elucidation during bioanalytical studies. Scientists rely on these well-characterized reference materials to ensure compliance with regulatory standards and to maintain the safety and efficacy of therapeutic drug formulations throughout the development lifecycle.